Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of a New System of Ultrasound (US) Guided - Radiofrequency Ablation (RFA) on Explanted Pancreas From Patients With Solid Pancreatic Masses: Study of Efficacy

NCT06371716 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06371716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of a New System of Ultrasound (US) Guided - Radiofrequency Ablation (RFA) on Explanted Pancreas From Patients With Solid Pancreatic Masses: Study of Efficacy
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Terminated
Start date
September 12, 2019
Completion date
June 12, 2020
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endoscopic ultrasound, pancreatic cancer, radiofrequency ablation